MILAN, May 30, 2024 /PRNewswire/ -- NTC, an International pharmaceutical company with headquarter in Italy, with a specific focus in ophthalmology and with a significant portfolio in gynecology and gastroenterology too, continues in its certification path and receives the fifth Medical Device Regulation (MDR) Certificate approval, this time for its hypertonic ophthalmic solution based on NaCl 5% multidose.